BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25654289)

  • 1. [RUCAM scale-based diagnosis, clinical features and prognosis of 140 cases of drug-induced liver injury].
    Hao K; Yu Y; He C; Wang M; Wang S; Li X
    Zhonghua Gan Zang Bing Za Zhi; 2014 Dec; 22(12):938-41. PubMed ID: 25654289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
    Teschke R; Méndez-Sánchez N; Eickhoff A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Spectrum and Outcome of Pediatric Drug Induced Liver Injury.
    Kumar A; Sood V; Khanna R; Verma SK; Mehra N; Rawat D; Alam S
    Indian J Pediatr; 2018 Aug; 85(8):676-678. PubMed ID: 29247427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
    Teschke R; Schulze J; Eickhoff A; Danan G
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
    Teschke R; Danan G
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study.
    Rodríguez A; García-García I; Martínez de Soto L; Gómez López De Las Huertas A; Borobia AM; González-Torbay A; Akatbach-Bousaid I; González-Muñoz M; Ramírez E
    Front Pharmacol; 2022; 13():819589. PubMed ID: 35370653
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Features and Risk Factors for Drug-Induced Liver Injury: A Retrospective Study From China.
    Ma X; Chen Z; An J; Zhang C
    Clin Ther; 2024 May; ():. PubMed ID: 38821767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method.
    Ye L; Feng Z; Huang L; Guo C; Wu X; He L; Tan W; Wang Y; Wu X; Hu B; Li T; Yang G; Chengxian G; He Q
    Front Pharmacol; 2021; 12():790108. PubMed ID: 34987403
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of liver biopsy in the era of clinical prediction scores for "drug-induced liver injury" (DILI): experience of a tertiary referral hospital.
    Costa-Moreira P; Gaspar R; Pereira P; Lopes S; Canão P; Lopes J; Carneiro F; Macedo G
    Virchows Arch; 2020 Oct; 477(4):517-525. PubMed ID: 32377873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM).
    Teschke R; Danan G
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33800917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China.
    Chen Y; Wang C; Yang H; Huang P; Shi J; Tong Y; Jiang J; Zhang X; Chen W; Xuan Z
    Biomed Res Int; 2021; 2021():8894498. PubMed ID: 33954202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
    Teschke R
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
    Danan G; Teschke R
    Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective nationwide study of drug-induced liver injury in Korea.
    Suk KT; Kim DJ; Kim CH; Park SH; Yoon JH; Kim YS; Baik GH; Kim JB; Kweon YO; Kim BI; Kim SH; Kim IH; Kim JH; Nam SW; Paik YH; Suh JI; Sohn JH; Ahn BM; Um SH; Lee HJ; Cho M; Jang MK; Choi SK; Hwang SG; Sung HT; Choi JY; Han KH
    Am J Gastroenterol; 2012 Sep; 107(9):1380-7. PubMed ID: 22733303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
    Shen T; Liu Y; Shang J; Xie Q; Li J; Yan M; Xu J; Niu J; Liu J; Watkins PB; Aithal GP; Andrade RJ; Dou X; Yao L; Lv F; Wang Q; Li Y; Zhou X; Zhang Y; Zong P; Wan B; Zou Z; Yang D; Nie Y; Li D; Wang Y; Han X; Zhuang H; Mao Y; Chen C
    Gastroenterology; 2019 Jun; 156(8):2230-2241.e11. PubMed ID: 30742832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.
    Sunil Kumar N; Remalayam B; Thomas V; Ramachandran TM; Sunil Kumar K
    J Clin Exp Hepatol; 2021; 11(2):163-170. PubMed ID: 33746440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.
    Danjuma MI; Almasri H; Alshokri S; Khir FK; Elmalik A; Battikh NG; Abdallah IMH; Elshafei M; Fatima H; Mohamed MFH; Maghoub Y; Hussain T; Kamal I; Anwer Z; Bidmos MA; Elzouki AN
    BMC Geriatr; 2020 Sep; 20(1):346. PubMed ID: 32928134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients.
    Zhu Y; Niu M; Chen J; Zou ZS; Ma ZJ; Liu SH; Wang RL; He TT; Song HB; Wang ZX; Pu SB; Ma X; Wang LF; Bai ZF; Zhao YL; Li YG; Wang JB; Xiao XH;
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1476-82. PubMed ID: 26896664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt.
    Alhaddad O; Elsabaawy M; Abdelsameea E; Abdallah A; Shabaan A; Ehsan N; Elrefaey A; Elsabaawy D; Salama M
    Sci Rep; 2020 Mar; 10(1):5124. PubMed ID: 32198411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.